Monocyte Chemotactic Protein‐4 (MCP‐4; CCL‐13): A Biomarker of Asthma

References

• Vignola A M, Chanez P, Campbell A M, Souques F, Lebel B, Enander I, Bousquet J. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998; 157(2)403–409, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wardlaw A J, Dunnette S, Gleich G J, Collins J V, Kay A B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137(1)62–69, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Robinson D S, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley A M, Corrigan C, Durham S R, Kay A B. Predominant TH2‐like bronchoalveolar T‐lymphocyte population in atopic asthma. N Engl J Med 1992; 326(5)298–304, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Busse W W, Lemanske R F, Jr. Asthma. N Engl J Med 2001; 344(5)350–362, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Luster A D. Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338(7)436–445, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Garcia‐Zepeda E A, Combadiere C, Rothenberg M E, Sarafi M N, Lavigne F, Hamid Q, Murphy P M, Luster A D. Human monocyte chemoattractant protein (MCP)‐4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)‐2 and ‐3. J Immunol 1996; 57(12)5613–5626
   Google Scholar
• Stellato C, Collins P, Ponath P D, Soler D, Newman W, La Rosa G, Li H, White J, Schwiebert L M, Bickel C, Liu M, Bochner B S, Williams T, Schleimer R P. Production of the novel C–C chemokine MCP‐4 by airway cells and comparison of its biological activity to other C–C chemokines. J Clin Invest 1997; 99(5)926–936, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Berkhout T A, Sarau H M, Moores K, White J R, Elshourbagy N, Appelbaum E, Reape R J, Brawner M, Makwana J, Foley J J, Schmidt D B, Imburgia C, McNulty D, Matthews J, O'Donnell K, O'Shannessy D, Scott M, Groot P H, Macphee C. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP‐4) that binds and signals through the CC chemokine receptor 2B. J Biol Chem 1997; 272(26)16404–16413, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Godiska R, Chantry D, Raport C J, Schweickart V L, Trong H L, Gray P W. Monocyte chemotactic protein‐4, tissue‐specific expression and signaling through CC chemokine receptor‐2. J Leukoc Biol 1997; 61(3)353–360, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Blanpain C, Migeotte I, Lee B, Vakili J, Doranz B J, Govaerts C, Vassart G, Doms R W, Parmentier M. CCR5 binds multiple CC‐chemokines, MCP‐3 acts as a natural antagonist. Blood 1999; 94(6)1899–1905, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ruffing N, Sullivan N, Sharmeen L, Sodroski J, Wu L. CCR5 has an expanded ligand‐binding repertoire and is the primary receptor used by MCP‐2 on activated T cells. Cell Immunol 1998; 189(2)160–168, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Uguccioni M, Mackay C R, Ochensberger B, Loetscher P, Rhis S, LaRosa G J, Rao P, Ponath P D, Baggiolini M, Dahinden C A. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP‐4, and other chemokines. J Clin Invest 1997; 100(5)1137–1143, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Petering H, Hochstetter R, Kimmig D, Smolarski R, Kapp A, Elsner J. Detection of MCP‐4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils. J Immunol 1998; 160(2)555–558, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Ying S, Meng Q, Zeibecoglou K, Robinson D S, Macfarlane A, Humbert M, Kay A B. Eosinophil chemotactic chemokines (eotaxin, eotaxin‐2, RANTES, monocyte chemoattractant protein‐3 (MCP‐3), and MCP‐4), and C–C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999; 163(11)6321–6329, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lamkhioued B, Garcia‐Zepeda E A, Abi‐Younes S, Nakamura H, Jedrzkiewicz S, Wagner L, Renzi P M, Allakhverdi Z, Lilly C, Hamid Q, Luster A D. Monocyte chemoattractant protein (MCP)‐4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Am J Respir Crit Care Med 2000; 162(2 Pt 1)723–732, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Taha R A, Minshall E M, Miotto D, Shimbara A, Luster A, Hogg J C, Hamid Q A. Eotaxin and monocyte chemotactic protein‐4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999; 103(3 Pt 1)476–483, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Taha R A, Laberge S, Hamid Q, Olivenstein R. Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein‐4, and interleukin‐16 in induced sputum in asthmatic patients. Chest 2001; 120(2)595–601, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Lilly C M, Woodruff P G, Camargo C A, Jr, Nakamura H, Drazen J M, Nadel E, Hanrahan J P. Elevated plasma eotaxin levels in patients with acute asthma. J Allergy Clin Immunol 1999; 104(4 Pt 1)786–790, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Cydulka R K, Emerman C L, Schreiber D, Molander K H, Woodruff P G, Camargo C A, Jr. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999; 160(3)887–892, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Zimmerman J L, Woodruff P G, Clark S, Camargo C A, Jr. Relation between phase of menstrual cycle and emergency department visits for acute asthma. Am J Respir Crit Care Med 2000; 162(2 Pt 1)512–515, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• American Thoracic Society. Lung function testing, selection of reference values and interpretive strategies. Am Rev Respir Dis 1991; 144(5)1202–1218
   PubMed Web of Science ®Google Scholar
• Roca J, Sanchis J, Agusti‐Vidal A, Segarra F, Navajas D, Rodriguez‐Roisin R, Casan P, Sans S. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22(3)217–224, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Miotto D, Christodoulopoulos P, Olivenstein R, Taha R, Cameron L, Tsicopoulos A, Tonnel A B, Fahy O, Lafitte J J, Luster A D, Wallaert B, Mapp C E, Hamid Q. Expression of IFN‐gamma‐inducible protein, monocyte chemotactic proteins 1, 3, and 4, and eotaxin in TH1‐ and TH2‐mediated lung diseases. J Allergy Clin Immunol 2001; 107(4)664–670, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nakamura H, Weiss S T, Israel E, Luster A D, Drazen J M, Lilly C M. Eotaxin and impaired lung function in asthma. Am J Respir Crit Care Med 1999; 160(6)1952–1956, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar